Følling I - Search Results

1

A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.

Raeder H, Bjørkhaug L, Johansson S, Mangseth K, Sagen JV, Hunting A, Følling I, Johansen O, Bjørgaas M, Paus PN, Søvik O, Molven A, Njølstad PR. Raeder H, et al. Among authors: folling i. Diabetes. 2006 Jun;55(6):1899-903. doi: 10.2337/db05-1677. Diabetes. 2006. PMID: 16731861

2

[Non-insulin dependent diabetes in children and adolescents].

Njølstad PR, Søvik O, Bell GI, Cockburn BN, Følling I, Sagen J. Njølstad PR, et al. Among authors: folling i. Tidsskr Nor Laegeforen. 1998 Mar 10;118(7):1054-7. Tidsskr Nor Laegeforen. 1998. PMID: 9531829 Norwegian.

3

Maturity-onset diabetes of the young. Studies in a Norwegian family.

Heiervang E, Følling I, Søvik O, Sandnes T, Myrmael T, Moen T, Myking O. Heiervang E, et al. Among authors: folling i. Acta Paediatr Scand. 1989 Jan;78(1):74-80. doi: 10.1111/j.1651-2227.1989.tb10890.x. Acta Paediatr Scand. 1989. PMID: 2645741

4

Hyperexcitability to sulphonylurea in MODY3.

Søvik O, Njølstad P, Følling I, Sagen J, Cockburn BN, Bell GI. Søvik O, et al. Among authors: folling i. Diabetologia. 1998 May;41(5):607-8. doi: 10.1007/s001250050956. Diabetologia. 1998. PMID: 9628283 No abstract available.

5

A gel electrophoresis method for detection of mitochondrial DNA mutation (3243 tRNA(Leu (UUR))) applied to a Norwegian family with diabetes mellitus and hearing loss.

Akbari M, Skjelbred C, Følling I, Sagen J, Krokan HE. Akbari M, et al. Among authors: folling i. Scand J Clin Lab Invest. 2004 Apr;64(2):86-92. doi: 10.1080/00365510410004209. Scand J Clin Lab Invest. 2004. PMID: 15115244

6

Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease.

Carlsen SM, Grill V, Følling I. Carlsen SM, et al. Among authors: folling i. Diabetes Res Clin Pract. 1998 Jan;39(1):47-54. doi: 10.1016/s0168-8227(97)00121-6. Diabetes Res Clin Pract. 1998. PMID: 9597374 Clinical Trial.

7

Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease.

Carlsen SM, Waage A, Grill V, Følling I. Carlsen SM, et al. Among authors: folling i. Cytokine. 1998 Jan;10(1):66-9. doi: 10.1006/cyto.1997.0253. Cytokine. 1998. PMID: 9505147

8

[Treatment of insulin-dependent diabetes].

Hanssen KF, Følling I. Hanssen KF, et al. Among authors: folling i. Tidsskr Nor Laegeforen. 1991 Jun 20;111(16):1982-3. Tidsskr Nor Laegeforen. 1991. PMID: 1866733 Review. Norwegian. No abstract available.

9

[New diagnostic criteria for diabetes mellitus--why?].

Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J. Grill V, et al. Among authors: folling i. Tidsskr Nor Laegeforen. 2000 Jun 20;120(16):1876-7. Tidsskr Nor Laegeforen. 2000. PMID: 10925616 Free article. Norwegian.

10

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

Carlsen SM, Følling I, Grill V, Bjerve KS, Schneede J, Refsum H. Carlsen SM, et al. Among authors: folling i. Scand J Clin Lab Invest. 1997 Oct;57(6):521-7. doi: 10.3109/00365519709084603. Scand J Clin Lab Invest. 1997. PMID: 9350072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters